Minimal invasive cardiac valve procedures seem to be beneficial for patients with
sarcopenia but frailty may be more adequate to evaluate perioperative risk in severly
compromised and older patients.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Seminars in Thoracic and Cardiovascular SurgeryAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Sarcopenia: origins and clinical relevance.J Nutr. 1997; 127: 990S-991S
- Impact of sarcopenia on outcomes of minimally invasive cardiac surgery.Semin Thorac Cardiovasc Surg. 2023; 35: 77-85
- 2021 ESC/EACTS Guidelines for the management of valvular heart disease. Developed by the Task Force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS).Eur J Cardio-thorac Surg. 2021; (in press)
- European Working Group on Sarcopenia in Older People: Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People.Age Ageing. 2010; 39: 412-423
- Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) "cachexia-anorexia in chronic wasting diseases" and "nutrition in geriatrics".Clin Nutr. 2010; 29: 154-159
- Frailty in older adults: evidence for a phenotype.J Gerontol A Biol Sci Med Sci. 2001; 56: 146-156
Article info
Publication history
Published online: December 12, 2021
Footnotes
Disclosures: Thierry Carrel has no disclosure in relation with this work
Identification
Copyright
© 2021 Elsevier Inc. All rights reserved.
ScienceDirect
Access this article on ScienceDirectLinked Article
- Impact of Sarcopenia on Outcomes of Minimally Invasive Cardiac SurgerySeminars in Thoracic and Cardiovascular SurgeryVol. 35Issue 1
- PreviewSarcopenia is an objective marker of poor outcome following cardiac surgery through median sternotomy. However, the clinical impact of sarcopenia after minimally invasive cardiac surgery (MICS) has not been well established. This study aimed to analyze the influence of sarcopenia on the early and late outcomes following MICS. We retrospectively examined 1248 patients who underwent MICS via right mini-thoracotomy or upper sternotomy between February 2009 and April 2020. Patients older than 65 years who underwent preoperative computed tomography were enrolled.
- Full-Text
- Preview
